Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt-Reference-Cited by-同舟云学术

Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt

Published:2014-02-07 Issue:8 Volume:58 Page:1064-1071
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Obach Dorothée,Deuffic-Burban Sylvie,Esmat Gamal,Anwar Wagida A.,Dewedar Sahar,Canva Valérie,Cousien Anthony,Doss Wahid,Mostafa Aya,Pol Stanislas,Buti Maria,Siebert Uwe,Fontanet Arnaud,Mohamed Mostafa K.,Yazdanpanah Yazdan

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/58/8/1064/17351927/ciu066.pdf

Reference33 articles.

1. Egypt demographic and health survey 2008;El-Zanaty,2009

2. Genetic variability of hepatitis C virus in south Egypt and its possible clinical implication;Elkady;J Med Virol,2009

3. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt;Frank;Lancet,2000

4. Genetic epidemiology of hepatitis C virus throughout Egypt;Ray;J Infect Dis,2000

5. Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS;Ford;Clin Infect Dis,2012

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study;BMJ Public Health;2024-03

2. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model;Liver International;2023-04-18

3. A Systematic Review on Economic Evaluation Studies of Diagnostic and Therapeutic Interventions in the Middle East and North Africa;Applied Health Economics and Health Policy;2021-12-21

4. Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan;Journal of Viral Hepatitis;2020-11-04

5. Long‐term clinical benefits of Sofosbuvir‐based direct antiviral regimens for patients with chronic hepatitis C in Central and West Africa;Liver International;2020-08-31